Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsey T Brinton

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cells|September 28, 2021
Plectin in Cancer: From Biomarker to Therapeutic TargetSamantha M Perez, Lindsey T Brinton, Kimberly A Kelly
Cellular and Molecular Life Sciences : CMLS|October 23, 2014
Formation and role of exosomes in cancerLindsey T Brinton, Hillary S Sloane, Mark Kester, et al.
Cancer Genomics & Proteomics|November 20, 2012
Metastatic biomarker discovery through proteomicsLindsey T Brinton, Teresa A Brentnall, Jeffrey A Smith, et al.
Plos One|May 18, 2016
PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation SequencingLindsey T Brinton, Dustin K Bauknight, Siva Sai Krishna Dasa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2015
Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarctionSiva Sai Krishna Dasa, Ryo Suzuki, Michael Gutknecht, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal AdenocarcinomaJessica Hung, Samantha M Perez, Siva Sai Krishna Dasa, et al.
Cancers|June 18, 2020
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid LeukemiaLindsey T Brinton, Steven Sher, Katie Williams, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Journal of Hematology & Oncology|October 20, 2020
Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemiaLindsey T Brinton, Pu Zhang, Katie Williams, et al.
Molecular Cancer Therapeutics|September 14, 2021
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD-Positive AMLMegan E Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cells|September 28, 2021
Plectin in Cancer: From Biomarker to Therapeutic TargetSamantha M Perez, Lindsey T Brinton, Kimberly A Kelly
Cellular and Molecular Life Sciences : CMLS|October 23, 2014
Formation and role of exosomes in cancerLindsey T Brinton, Hillary S Sloane, Mark Kester, et al.
Cancer Genomics & Proteomics|November 20, 2012
Metastatic biomarker discovery through proteomicsLindsey T Brinton, Teresa A Brentnall, Jeffrey A Smith, et al.
Plos One|May 18, 2016
PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation SequencingLindsey T Brinton, Dustin K Bauknight, Siva Sai Krishna Dasa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2015
Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarctionSiva Sai Krishna Dasa, Ryo Suzuki, Michael Gutknecht, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal AdenocarcinomaJessica Hung, Samantha M Perez, Siva Sai Krishna Dasa, et al.
Cancers|June 18, 2020
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid LeukemiaLindsey T Brinton, Steven Sher, Katie Williams, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Journal of Hematology & Oncology|October 20, 2020
Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemiaLindsey T Brinton, Pu Zhang, Katie Williams, et al.
Molecular Cancer Therapeutics|September 14, 2021
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD-Positive AMLMegan E Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
Pageof 2